Calypte Biomedical Corp (CBMC) Financial Statements (2024 and earlier)

Company Profile

Business Address 5000 HOPYARD ROAD, SUITE 480
PLEASANTON, CA 94588
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments
Cash and cash equivalents
Receivables
Inventory, net of allowances, customer advances and progress billings
Inventory
Prepaid expense
Total current assets:
Noncurrent Assets
Property, plant and equipment
Intangible assets, net (including goodwill)
Intangible assets, net (excluding goodwill)
Other noncurrent assets
Total noncurrent assets:
TOTAL ASSETS:
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:
Employee-related liabilities
Other undisclosed accounts payable and accrued liabilities
Debt
Other undisclosed current liabilities
Total current liabilities:
Noncurrent Liabilities
Other undisclosed noncurrent liabilities
Total noncurrent liabilities:
Total liabilities:
Temporary equity, carrying amount
Equity
Equity, attributable to parent
Common stock
Additional paid in capital
Accumulated other comprehensive loss
Accumulated deficit
Other undisclosed equity
Total equity:
TOTAL LIABILITIES AND EQUITY:

Income Statement (P&L) ($ in thousands)

12/31/2012
Revenues
(Revenue, Net)
Cost of revenue
(Cost of Goods and Services Sold)
Gross profit:
Operating expenses
Other undisclosed operating income
Operating loss:
Interest and debt expense
Other undisclosed income from continuing operations before equity method investments, income taxes
Loss from continuing operations:
Loss before gain (loss) on sale of properties:
Net loss available to common stockholders, diluted:

Comprehensive Income ($ in thousands)

12/31/2012
Net loss:
Comprehensive loss, net of tax, attributable to parent:

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: